Published in World J Clin Oncol on February 10, 2013
American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol (2007) 14.29
Cathepsin D--many functions of one aspartic protease. Crit Rev Oncol Hematol (2008) 2.26
Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol (2007) 2.06
Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. Cancer Res (2010) 1.79
Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer. J Proteome Res (2010) 1.75
Autoantibody signatures: progress and perspectives for early cancer detection. J Cell Mol Med (2011) 1.45
Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene (2002) 1.42
Cathepsin D in cancer metastasis: a protease and a ligand. APMIS (1999) 1.24
The propeptide of cathepsin D increases proliferation, invasion and metastasis of breast cancer cells. Int J Oncol (2008) 1.10
Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications. Clin Exp Metastasis (2004) 1.00
Procathepsin D as a tumor marker, anti-cancer drug or screening agent. Anticancer Agents Med Chem (2012) 0.89
Cathepsin D antigenic epitopes identified by the humoral responses of ovarian cancer patients. Cancer Immunol Immunother (1998) 0.87
Procathepsin D in breast cancer: what do we know? Effects of ribozymes and other inhibitors. Cancer Gene Ther (2002) 0.86
Procathepsin D and cancer: From molecular biology to clinical applications. World J Clin Oncol (2010) 0.83
Comparative autoantibody profiling before and after appearance of malignance: identification of anti-cathepsin D autoantibody as a promising diagnostic marker for lung cancer. Biochem Biophys Res Commun (2012) 0.79
Cathepsin D--many functions of one aspartic protease. Crit Rev Oncol Hematol (2008) 2.26
The propeptide of cathepsin D increases proliferation, invasion and metastasis of breast cancer cells. Int J Oncol (2008) 1.10
Glucan-immunostimulant, adjuvant, potential drug. World J Clin Oncol (2011) 1.01
Role of activation peptide of procathepsin D in proliferation and invasion of lung cancer cells. Anticancer Res (2007) 0.89
Procathepsin D as a tumor marker, anti-cancer drug or screening agent. Anticancer Agents Med Chem (2012) 0.89
Procathepsin D secreted by HaCaT keratinocyte cells - A novel regulator of keratinocyte growth. Eur J Cell Biol (2007) 0.86
Procathepsin D in breast cancer: what do we know? Effects of ribozymes and other inhibitors. Cancer Gene Ther (2002) 0.86
Depletion of procathepsin D gene expression by RNA interference: a potential therapeutic target for breast cancer. Cancer Biol Ther (2007) 0.84
Ribozyme-targeting procathepsin D and its effect on invasion and growth of breast cancer cells: an implication in breast cancer therapy. Int J Oncol (2007) 0.83
Effect of procathepsin D activation peptide on gene expression of breast cancer cells. Cancer Lett (2005) 0.79
2-DE analysis of breast cancer cell lines 1833 and 4175 with distinct metastatic organ-specific potentials: comparison with parental cell line MDA-MB-231. Oncol Rep (2008) 0.79
Procathepsin D expression correlates with invasive and metastatic phenotype of MDA-MB-231 derived cell lines. Int J Biol Macromol (2007) 0.78
Cytokines affect procathepsin D-stimulated proliferation of breast cancer cells. Anticancer Res (2002) 0.76
Procathepsin d involvement in chemoresistance of cancer cells. N Am J Med Sci (2012) 0.75